The Asia-Pacific region is home to the No. 2 and No. 3 global pharma markets, more than 60 percent of the world’s population and its fastest-aging country. In this hard-to-crack environment with such varying needs, a keen understanding of market-by-market requirements and regulations is a must.
Clinical trials conducted outside the region may or may not be applicable in Asia, so knowing the marketing, pricing and reimbursement implications ahead of time is a must to demonstrate and communicate value.